|
1
|
Harding D, Giles SL, Brown MRD, Ter Haar
GR, van den Bosch M, Bartels LW, Kim YS, Deppe M and deSouza NM:
Evaluation of quality of life outcomes following palliative
treatment of bone metastases with magnetic resonance-guided high
intensity focused ultrasound: An international multicentre study.
Clin Oncol (R Coll Radiol). 30:233–242. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buga S and Sarria JE: The management of
pain in metastatic bone disease. Cancer Control. 19:154–166. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mercadante S and Arcuri E: Breakthrough
pain in cancer patients: Pathophysiology and treatment. Cancer
Treat Rev. 24:425–432. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown M and Farquhar-Smith P: Pain in
cancer survivors; filling in the gaps. Br J Anaesth. 119:723–736.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Frost CØ, Hansen RR and Heegaard AM: Bone
pain: Current and future treatments. Curr Opin Pharmacol. 28:31–37.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahmad I, Ahmed MM, Ahsraf MF, Naeem A,
Tasleem A, Ahmed M and Farooqi MS: Pain management in metastatic
bone disease: A literature review. Cureus. 10:e32862018.PubMed/NCBI
|
|
7
|
Pöyhiä R and Kalso EA: Antinociceptive
effects and central nervous system depression caused by oxycodone
and morphine in rats. Pharmacol Toxicol. 70:125–130. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cooper ZD, Bedi G, Ramesh D, Balter R,
Comer SD and Haney M: Impact of co-administration of oxycodone and
smoked cannabis on analgesia and abuse liability.
Neuropsychopharmacology. 43:2046–2055. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coe MA, Nuzzo PA, Lofwall MR and Walsh SL:
Effects of short-term oxycodone maintenance on experimental pain
responses in physically dependent opioid abusers. J Pain.
18:825–834. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hanamura K, Washburn H, Sheffler-Collins
SL, Xia NL, Henderson N, Tillu DV, Hassler S, Spellman DS, Zhang G,
Neubert TA, et al: Extracellular phosphorylation of a receptor
tyrosine kinase controls synaptic localization of NMDA receptors
and regulates pathological pain. PLoS Biol. 15:e20024572017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pareek TK, Keller J, Kesavapany S, Agarwal
N, Kuner R, Pant HC, Iadarola MJ, Brady RO and Kulkarni AB:
Cyclin-dependent kinase 5 modulates nociceptive signaling through
direct phosphorylation of transient receptor potential vanilloid 1.
Proc Natl Acad Sci USA. 104:660–665. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo N, Zhang X, Huang M, Li X, Li Y, Zhou
X and Bai J: Geranylgeranylacetone blocks the reinstatement of
morphine-conditioned place preference. Neuropharmacology.
143:63–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen SP, Sun J, Zhou YQ, Cao F, Braun C,
Luo F, Ye DW and Tian YK: Sinomenine attenuates cancer-induced bone
pain via suppressing microglial JAK2/STAT3 and neuronal CAMKII/CREB
cascades in rat models. Mol Pain. 14:17448069187932322018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vaughan CW, Ingram SL, Connor MA and
Christie MJ: How opioids inhibit GABA-mediated neurotransmission.
Nature. 390:611–614. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Scherer PC, Zaccor NW, Neumann NM, Vasavda
C, Barrow R, Ewald AJ, Rao F, Sumner CJ and Snyder SH: TRPV1 is a
physiological regulator of µ-opioid receptors. Proc Natl Acad Sci
USA. 114:13561–13566. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gaspari S, Cogliani V, Manouras L,
Anderson EM, Mitsi V, Avrampou K, Carr FB and Zachariou V: RGS9-2
modulates responses to oxycodone in pain-free and chronic pain
states. Neuropsychopharmacology. 42:1548–1556. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Largent-Milnes TM, Guo W, Wang HY, Burns
LH and Vanderah TW: Oxycodone plus ultra-low-dose naltrexone
attenuates neuropathic pain and associated mu-opioid receptor-Gs
coupling. J Pain. 9:700–713. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Wang YH, Zhang XH, Ge HY,
Arendt-Nielsen L, Shao JM and Yue SW: Proteomic analysis of
differential proteins related to the neuropathic pain and
neuroprotection in the dorsal root ganglion following its chronic
compression in rats. Exp Brain Res. 189:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Y, Chen S, Xu Q, Yu K, Wang J, Qiao L,
Meng F and Liu J: Proteomic analysis of differential proteins
related to anti-nociceptive effect of electroacupuncture in the
hypothalamus following neuropathic pain in rats. Neurochem Res.
38:1467–1478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lind AL, Emami Khoonsari P, Sjödin M,
Katila L, Wetterhall M, Gordh T and Kultima K: Spinal cord
stimulation alters protein levels in the cerebrospinal fluid of
neuropathic pain patients: A proteomic mass spectrometric analysis.
Neuromodulation. 19:549–562. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mertins P, Udeshi ND, Clauser KR, Mani DR,
Patel J, Ong SE, Jaffe JD and Carr SA: iTRAQ labeling is superior
to mTRAQ for quantitative global proteomics and phosphoproteomics.
Mol Cell Proteomics. 11:M111.014423. 2012. View Article : Google Scholar :
|
|
22
|
McAlister GC, Huttlin EL, Haas W, Ting L,
Jedrychowski MP, Rogers JC, Kuhn K, Pike I, Grothe RA, Blethrow JD
and Gygi SP: Increasing the multiplexing capacity of TMTs using
reporter ion isotopologues with isobaric masses. Anal Chem.
84:7469–7478. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu
J, Yan MF, Zhang YQ, Wu GC and Wang YQ: A rat model of bone cancer
pain induced by intra-tibia inoculation of Walker 256 mammary gland
carcinoma cells. Biochem Biophys Res Commun. 345:1292–1298. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
An K, Rong H, Ni H, Zhu C, Xu L, Liu Q,
Chen Y, Zheng Y, Huang B and Yao M: Spinal PKC activation-Induced
neuronal HMGB1 translocation contributes to hyperalgesia in a bone
cancer pain model in rats. Exp Neurol. 303:80–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang LX and Wang ZJ: Animal and cellular
models of chronic pain. Adv Drug Deliv Rev. 55:949–965. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Ni H, Li H, Deng H, Xu LS, Xu S,
Zhen Y, Shen H, Pan H and Yao M: Nuclear factor kappa B regulated
monocyte chemoattractant protein-1/chemokine CC motif receptor-2
expressing in spinal cord contributes to the maintenance of
cancer-induced bone pain in rats. Mol Pain.
14:17448069187886812018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu M, Yao M, Wang H, Xu L, Zheng Y, Huang
B, Ni H, Xu S, Zhou X and Lian Q: P2Y12
receptor-mediated activation of spinal microglia and p38MAPK
pathway contribute to cancer-induced bone pain. J Pain Res.
10:417–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kato A, Minami K, Ito H, Tomii T,
Matsumoto M, Orita S, Kihara T, Narita M and Suzuki T:
Oxycodone-induced analgesic effects in a bone cancer pain model in
mice. Oncology. 74 (Suppl 1):S55–S60. 2008. View Article : Google Scholar
|
|
29
|
Nielsen CK, Ross FB, Lotfipour S, Saini
KS, Edwards SR and Smith MT: Oxycodone and morphine have distinctly
different pharmacological profiles: Radioligand binding and
behavioural studies in two rat models of neuropathic pain. Pain.
132:289–300. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Larsen MR, Thingholm TE, Jensen ON,
Roepstorff P and Jørgensen TJ: Highly selective enrichment of
phosphorylated peptides from peptide mixtures using titanium
dioxide microcolumns. Mol Cell Proteomics. 4:873–886. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wiśniewski JR, Zougman A, Nagaraj N and
Mann M: Universal sample preparation method for proteome analysis.
Nat Methods. 6:359–362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Olsen JV, Blagoev B, Gnad F, Macek B,
Kumar C, Mortensen P and Mann M: Global, in vivo, and site-specific
phosphorylation dynamics in signaling networks. Cell. 127:635–648.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
The Gene Ontology Consortium, . The Gene
Ontology Resource: 20 years and still GOing strong. Nucleic Acids
Res. 47(D1): D330–D338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Götz S, García-Gómez JM, Terol J, Williams
TD, Nagaraj SH, Nueda MJ, Robles M, Talón M, Dopazo J and Conesa A:
High-throughput functional annotation and data mining with the
Blast2GO suite. Nucleic Acids Res. 36:3420–3435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peckham EM and Traynor JR: Comparison of
the antinociceptive response to morphine and morphine-like
compounds in male and female Sprague-Dawley rats. J Pharmacol Exp
Ther. 316:1195–1201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lemberg KK, Kontinen VK, Siiskonen AO,
Viljakka KM, Yli-Kauhaluoma JT, Korpi ER and Kalso EA:
Antinociception by spinal and systemic oxycodone: Why does the
route make a difference? In vitro and in vivo studies in rats.
Anesthesiology. 105:801–812. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schwei MJ, Honore P, Rogers SD,
Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR and Mantyh
PW: Neurochemical and cellular reorganization of the spinal cord in
a murine model of bone cancer pain. J Neurosci. 19:10886–10897.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cain DM, Wacnik PW, Turner M,
Wendelschafer-Crabb G, Kennedy WR, Wilcox GL and Simone DA:
Functional interactions between tumor and peripheral nerve: Changes
in excitability and morphology of primary afferent fibers in a
murine model of cancer pain. J Neurosci. 21:9367–9376. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li H, Li Y, Lei Z, Wang K and Guo A:
Transformation of odor selectivity from projection neurons to
single mushroom body neurons mapped with dual-color calcium
imaging. Proc Natl Acad Sci USA. 110:12084–12089. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zheng R, Yi X, Lu W and Chen T: Stability
of analytic neural networks with event-triggered synaptic
feedbacks. IEEE Trans Neural Netw Learn Syst. 27:483–494. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Steinert JR, Kopp-Scheinpflug C, Baker C,
Challiss RA, Mistry R, Haustein MD, Griffin SJ, Tong H, Graham BP
and Forsythe ID: Nitric oxide is a volume transmitter regulating
postsynaptic excitability at a glutamatergic synapse. Neuron.
60:642–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ko HG, Choi JH, Park DI, Kang SJ, Lim CS,
Sim SE, Shim J, Kim JI, Kim S, Choi TH, et al: Rapid turnover of
cortical NCAM1 regulates synaptic reorganization after peripheral
nerve injury. Cell Rep. 22:748–759. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chirila AM, Brown TE, Bishop RA, Bellono
NW, Pucci FG and Kauer JA: Long-term potentiation of glycinergic
synapses triggered by interleukin 1β. Proc. Natl Acad Sci USA.
111:8263–8268. 2014. View Article : Google Scholar
|
|
45
|
Huang LE, Guo SH, Thitiseranee L, Yang Y,
Zhou YF and Yao YX: N-methyl D-aspartate receptor subtype 2B
antagonist, Ro 25–6981, attenuates neuropathic pain by inhibiting
postsynaptic density 95 expression. Sci Rep. 8:78482018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee JO, Kim N, Lee HJ, Lee YW, Kim JK, Kim
HI, Lee SK, Kim SJ, Park SH and Kim HS: Visfatin, a novel
adipokine, stimulates glucose uptake through the Ca2 +-dependent
AMPK-p38 MAPK pathway in C2C12 skeletal muscle cells. J Mol
Endocrinol. 54:251–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cui H, Hayashi A, Sun HS, Belmares MP,
Cobey C, Phan T, Schweizer J, Salter MW, Wang YT, Tasker RA, et al:
PDZ protein interactions underlying NMDA receptor-mediated
excitotoxicity and neuroprotection by PSD-95 inhibitors. J
Neurosci. 27:9901–9915. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fan J, Cowan CM, Zhang LY, Hayden MR and
Raymond LA: Interaction of postsynaptic density protein-95 with
NMDA receptors influences excitotoxicity in the yeast artificial
chromosome mouse model of Huntington's disease. J Neurosci.
29:10928–10938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lee WH, Li LL, Chawla A, Hudmon A, Lai YY,
Courtney MJ and Hohmann AG: Disruption of nNOS-NOS1AP
protein-protein interactions suppresses neuropathic pain in mice.
Pain. 159:849–863. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Vickers CA, Stephens B, Bowen J,
Arbuthnott GW, Grant SG and Ingham CA: Neurone specific regulation
of dendritic spines in vivo by post synaptic density 95 protein
(PSD-95). Brain Res. 1090:89–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cuthbert PC, Stanford LE, Coba MP, Ainge
JA, Fink AE, Opazo P, Delgado JY, Komiyama NH, O'Dell TJ and Grant
SG: Synapse-associated protein 102/dlgh3 couples the NMDA receptor
to specific plasticity pathways and learning strategies. J
Neurosci. 27:2673–2682. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wei Z, Wu G and Chen BS: Regulation of
SAP102 synaptic targeting by phosphorylation. Mol Neurobiol.
55:6215–6226. 2018. View Article : Google Scholar : PubMed/NCBI
|
